On this page
Back to topElevance Health ELV
Elevance Health is the 130th largest S&P 500 company by market cap, worth $92.0 billion. Its board has 12 directors, 10 of them independent. 8 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 10.4% of the company.
- CEO
- Gail Boudreaux
- Chair
- Ramiro G. Peru
- Sector
- Health CareManaged Health Care
- Headquarters
- Indianapolis, Indiana
- Founded
- 1946
- Market cap
- $92.0B
- 130th largest, 6 Nov 2026 close
- Price to sales
- 0.5
- Market cap over revenue
- Per employee
- $947K
- Market cap over employees
- Connections
- 6
- Companies sharing people
Financials
Latest quarter
Q3 2026 figures from Elevance Health's earnings release.
Filed 21 Oct 2026
- Revenue
- $51.4B
- Up 1.4% year over year
- Net income
- $1.3B
- Up 13% year over year
- Diluted EPS
- $6.27
- Up 18% year over year
Reported figures
Figures from the release, against the same period a year earlier.
| Figure | Value | Change |
|---|---|---|
| Operating Revenue | $50.4B | +0.7% |
| Diluted EPS | $6.27 | +18% |
| Adjusted diluted EPS | $6.99 | +16% |
| Operating Gain | $1.3B | 0.0% |
| Adjusted Operating Gain | $1.3B | 0.0% |
| Operating Margin | 2.5% | -0.1 pts |
| Adjusted Operating Margin | 2.7% | 0.0 pts |
| Benefit expense ratio | 90.6% | -0.7 pts |
| Operating expense ratio | 11.4% | +0.9 pts |
| Adjusted operating expense ratio | 11.3% | +0.9 pts |
| Total operating revenue | $50.4B | +0.7% |
| Premiums | $41.7B | -0.2% |
| Product revenue | $6.5B | +4.8% |
| Service fees | $2.3B | +6.8% |
| Net investment income | $1.0B | +66% |
| Total revenues | $51.4B | +1.4% |
| Benefit expense | $37.8B | -0.9% |
| Cost of products sold | $5.6B | +4.8% |
| Operating expense | $5.8B | +9.1% |
| Net income | $1.3B | +13% |
| Shareholders' net income | $1.4B | +15% |
| Income before income tax expense | $1.8B | +28% |
| Income tax expense | $451M | +106% |
| Shareholders' earnings per diluted share | $6.27 | +18% |
| Figure | Value | Change |
|---|---|---|
| Health Benefits operating revenue | $43.4B | +3.0% |
| Health Benefits operating gain | $400M | -33% |
| Health Benefits operating margin | 1% | -0.4 pts |
| Carelon operating revenue | $19.3B | +5.0% |
| Carelon operating gain | $900M | +13% |
| Carelon operating margin | 4.7% | +0.5 pts |
| CarelonRx operating revenue | $11.6B | +5.5% |
| Carelon Services operating revenue | $7.7B | +5.2% |
| CarelonRx operating gain | $616M | +11% |
| Carelon Services operating gain | $292M | +33% |
| Figure | Value | Change |
|---|---|---|
| Days in Claims Payable | 44.9 days | - |
| Operating cash flow | $1.3B | +8.3% |
| Medical membership | 44.9 million | -1.1% |
| CarelonRx Quarterly Adjusted Scripts | 82.6 million | -2.8% |
| Carelon Services Consumers Served | 91 million | -6.8% |
| Figure | Value | Change |
|---|---|---|
| FY 2026 diluted EPS guidanceFY 2026 outlook | $22.00 | - |
| FY 2026 adjusted diluted EPS guidanceFY 2026 outlook | $29.00 | - |
| FY 2026 operating cash flow guidanceFY 2026 outlook | $6.5B | - |
| Figure | Value | Change |
|---|---|---|
| Share repurchases | $330M | - |
| Dividends paid | $373M | - |
Financial history
Twelve months to 30 Sep 2026, from Elevance Health's quarterly filings.
Quarters since Dec 2021
- Revenue
- $202B
- Up 3.6% on the year before
- Net income
- $5.1B
- 2.5% of revenue
- Free cash flow
- $6.5B
- Operating cash flow less capital spending
- P/E
- 17.9
- Market cap over net income
Quarterly results
Each quarter's revenue, net income and free cash flow.
Dec 2021 to Sep 2026
| Quarter | Revenue | Net income |
|---|---|---|
| Sep 2026 | $51.4B | $1.4B |
| Jun 2026 | $50.5B | $1.5B |
| Mar 2026 | $50.2B | $1.8B |
| Dec 2025 | $49.7B | $547M |
| Sep 2025 | $50.7B | $1.2B |
| Jun 2025 | $49.8B | $1.7B |
| Mar 2025 | $48.9B | $2.2B |
| Dec 2024 | $45.4B | $418M |
| Sep 2024 | $45.1B | $1.0B |
| Jun 2024 | $43.9B | $2.3B |
| Mar 2024 | $42.6B | $2.2B |
| Dec 2023 | $42.6B | $856M |
| Sep 2023 | $42.8B | $1.3B |
| Jun 2023 | $43.7B | $1.9B |
| Mar 2023 | $42.2B | $2.0B |
| Dec 2022 | $39.9B | $996M |
| Sep 2022 | $39.9B | $1.6B |
| Jun 2022 | $38.6B | $1.7B |
| Mar 2022 | $38.1B | $1.8B |
| Dec 2021 | $36.6B | $1.2B |
Per employee
Twelve months to 30 Sep 2026, over 97,100 employees in Elevance Health's latest 10-K.
- Revenue
- $2.1M
- Operating profit
- $56K
- 2.7% of revenue
- Net income
- $53K
- 2.5% of revenue
Elevance Health's market cap since December 2008
Weekly, up to 6 Nov 2026
| Week ending | Market cap |
|---|---|
| 6 Nov 2026 | $92.0B |
| 26 Dec 2025 | $77.8B |
| 27 Dec 2024 | $86.1B |
| 29 Dec 2023 | $111B |
| 30 Dec 2022 | $123B |
| 31 Dec 2021 | $113B |
| 25 Dec 2020 | $76.8B |
| 27 Dec 2019 | $77.7B |
| 28 Dec 2018 | $67.0B |
| 29 Dec 2017 | $57.8B |
| 30 Dec 2016 | $37.9B |
| 25 Dec 2015 | $36.7B |
| 26 Dec 2014 | $34.1B |
| 27 Dec 2013 | $27.2B |
| 28 Dec 2012 | $18.2B |
| 30 Dec 2011 | $23.1B |
| 31 Dec 2010 | $22.4B |
| 25 Dec 2009 | $27.2B |
| 26 Dec 2008 | $20.5B |
Download Elevance Health's data as JSON, with the weekly market caps in billions of dollars from 5 Dec 2008.
Board and leadership
Board and officers
6 people here also hold roles at other S&P 500 companies.
Board from the proxy filed 27 Mar 2026; officers filed up to 30 Sep 2026
| Name | Title | Since | Independent | Committees | Age |
|---|---|---|---|---|---|
| Directors (12) | |||||
| Ramiro G. PeruChairIndependent · since 2004 · Compensation and Talent, GovernanceFormer Executive Vice President and CFO, Phelps Dodge CorporationOther boards: SM Energy | |||||
| Gail BoudreauxPresident and CEONot independent · since 2017Also at Target | |||||
| Steven H. CollisDirectorIndependent · since 2025 · Audit, FinanceFormer Executive Chairman, Cencora, Inc.Other boards: Bausch & Lomb | |||||
| Susan D. DeVoreDirectorIndependent · since 2021 · Compensation and Talent, Finance (chair)Former CEO, Premier, Inc.Also at SolventumOther boards: Unum Group | |||||
| Robert L. Dixon Jr.DirectorIndependent · since 2011 · Compensation and Talent, FinanceOwner, RD Factor, Inc.Other boards: Okta | |||||
| Lewis Hay IIIDirectorIndependent · since 2013 · Audit, FinanceOperating Advisor, Clayton, Dubilier & Rice, LLCAlso at L3Harris | |||||
| Bahija JallalDirectorIndependent · since 2018 · Compensation and Talent, Governance (chair)CEO, Immunocore Holdings plcOther boards: Immunocore Holdings | |||||
| Antonio F. NeriDirectorIndependent · since 2017 · Compensation and Talent (chair), GovernancePresident and CEO, Hewlett Packard Enterprise CompanyAlso at Hewlett Packard Enterprise | |||||
| Ryan M. SchneiderDirectorIndependent · since 2019 · Audit (chair), GovernanceFormer CEO and President, Anywhere Real Estate Inc. | |||||
| Amy W. SchulmanDirectorIndependent · since 2026 · Audit, FinanceManaging Partner, Polaris PartnersOther boards: Alnylam Pharmaceuticals | |||||
| Deanna D. StrableDirectorIndependent · since 2022 · Audit, GovernanceChairman of the Board, President and CEO, Principal Financial Group, Inc.Other boards: Principal Financial | |||||
| Deanna D. Strable-SoethoutDirectorAlso at Principal Financial Group | |||||
| Officers (8) | |||||
| Mark KayeEVP & CFOLast filed 4 Mar 2026 | |||||
| Ryan R. CraigEVP & Chief HR OfficerLast filed 4 Sep 2026 | |||||
| Peter D. HaytaianEVP & Pres Carelon & CarelonRxLast filed 4 Mar 2026 | |||||
| Charles Morgan Kendrick Jr.EVP & President, CommercialLast filed 9 Mar 2026 | |||||
| Ratnakar LavuEVP & Chief Digital Info OfrLast filed 4 Mar 2026 | |||||
| Felicia F. NorwoodEVP &Chief Health Benefits OfrAlso at Wells FargoLast filed 4 Mar 2026 | |||||
| Ronald W. PenczekCAO & ControllerLast filed 15 Jun 2026 | |||||
| Erin M. WesslingEVP & Chief Legal OfficerLast filed 4 Sep 2026 | |||||
Companies that share people with Elevance Health
Each person's title here, then at the other company.
- Hewlett Packard Enterprise HPE
- Antonio F. Neri: Director here, President and CEO there
- L3Harris LHX
- Lewis Hay III: Director here, Lead Independent Director there
- Principal Financial Group PFG
- Deanna D. Strable-Soethout: Director here, Chair, President and CEO there
- Solventum SOLV
- Susan D. DeVore: Director here, Director there
- Target TGT
- Gail Boudreaux: President and CEO here, Director there
- Wells Fargo WFC
- Felicia F. Norwood: EVP &Chief Health Benefits Ofr here, Director there
Owners and trading
Largest institutional holders
Each fund group's share of Elevance Health. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 6 Nov 2025 to 6 Nov 2026
Directors and officers sold $7.0 million of stock in 7 sales and bought $2.2 million in 3 purchases in the 12 months to 6 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 5 Nov 2026Sale | Ratnakar LavuEVP & Chief Digital Info Ofr | $572K |
| 22 Oct 2026Sale | Mark KayeEVP & CFO | $4.7M |
| 17 Jul 2026Buy | Gail BoudreauxPresident and CEO | $1.0M |
| 17 Jul 2026Buy | Ramiro G. PeruChair | $366K |
| 12 Jun 2026Sale | Ronald W. PenczekCAO & Controller | $149K |
| 11 Jun 2026Sale | Robert L. Dixon Jr.Director | $61K |
| 19 May 2026Sale | Ronald W. PenczekCAO & Controller | $617K |
| 12 Mar 2026Sale | Amy W. SchulmanDirector | $7K |
| 6 Mar 2026Sale | Charles Morgan Kendrick Jr.EVP & President, Commercial | $911K |
| 5 Mar 2026Buy | Steven H. CollisDirector | $870K |
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 27 Oct 2023 to 27 Oct 2026
16 people disclosed 32 purchases and 23 sales of Elevance Health stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 20 Jul 2026 | Rohit KhannaHouse, D-CA · Sold | $1K to $15K |
| 18 May 2026 | Markwayne MullinSecretary · Sold | $50K to $100K |
| 27 Apr 2026 | Donald J TrumpPresident · Bought | $15K to $50K |
| 27 Apr 2026 | Donald J TrumpPresident · Bought | $1K to $15K |
| 13 Apr 2026 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
| 10 Apr 2026 | Donald J TrumpPresident · Bought | $50K to $100K |
| 27 Mar 2026 | Alan ArmstrongSenate, R-OK · Bought | $1K to $15K |
| 18 Mar 2026 | Donald J TrumpPresident · Sold | $15K to $50K |
| 17 Mar 2026 | Donald J TrumpPresident · Sold | $250K to $500K |
| 24 Feb 2026 | Rohit KhannaHouse, D-CA · Bought | $15K to $50K |
Showing 10 of 55 trades
Workforce and hiring
Workforce
Headcount at 31 Dec 2025
- Employees
- 97,100
Employees, last 10 fiscal years
Up 16% in five years, from 83,400 in 2020 to 97,100 in 2025.
As of December 31, 2025, our employee population, including all full-time, part-time and temporary workers, consisted of approximately 97,100 individuals, 71,900 in the United States and 25,200 internationally.
Open roles
Jobs listed on Elevance Health's careers site, each counted once.
Daily, up to 3 Nov 2026
- Open roles
- 257
- On 3 Nov 2026
- Change
- -8
- Down 3.0% since 27 Oct 2026
- Top function
- Customer & Retail
- 54% of open roles
- Remote
- 22%
- Fully remote roles
Open roles in detail
27 Oct 2026 to 3 Nov 2026
Almost all are in the US.
| Role | Posted |
|---|---|
| Account SpecialistME-SOUTH PORTLAND, 2 GANNETT DR | 2 Nov 2026 |
| Advanced Analytics Consultant (Behavioral Health)IL-CHICAGO, 8600 W BRYN MAWR AVE, 10th & 11th FL; GA-ATLANTA, 740 W PEACHTREE ST NW; TN-NASHVILLE, 22 CENTURY BLVD, STE 310; IN-INDIANAPOLIS, 220 VIRGINIA AVE; OH-MASON, 4361 IRWIN SIMPSON RD; VA-NORFOLK, 5800 NORTHAMPTON BLVD | 2 Nov 2026 |
| Agile Product Manager - Payment Integrity/ClaimsFL-TAMPA, 5411 SKYCENTER DR, STE 700 & 800; GA-ATLANTA, 740 W PEACHTREE ST NW; IN-INDIANAPOLIS, 220 VIRGINIA AVE; OH-MASON, 4361 IRWIN SIMPSON RD | 2 Nov 2026 |
| Agile Product Owner – ServiceNow - Wellpoint FederalIN-INDIANAPOLIS, 220 VIRGINIA AVE; NY-EAST SYRACUSE, 5000 BRITTONFIELD PKWY, STE 100; TX-DENISON, 4616 HIGHWAY 75, STE 240; MD-BALTIMORE, 2245 ROLLING RUN DR, STE 9; OH-CINCINNATI, 3075 VANDERCAR WAY; MA-HINGHAM, 75 SGT WILLIAM B TERRY DR, STE 2012; PA-HARRISBURG, 2400 THEA DR, STE 3B; ME-SOUTH PORTLAND, 2 GANNETT DR | 2 Nov 2026 |
| Agile Sr. Product OwnerGA-ATLANTA, 740 W PEACHTREE ST NW; FL-TAMPA, 5411 SKYCENTER DR, STE 700 & 800; OH-MASON, 4361 IRWIN SIMPSON RD | 2 Nov 2026 |
| AI Solutions Engineer Lead SeniorGA-ATLANTA, 740 W PEACHTREE ST NW | 2 Nov 2026 |
| Business Change Director - Strategic Account Management & GrowthIN-INDIANAPOLIS, 220 VIRGINIA AVE | 2 Nov 2026 |
| Business Information Developer ConsultantMD-HANOVER, 7550 TEAGUE RD, STE 500 | 2 Nov 2026 |
| Day | Open roles |
|---|---|
| 3 Nov 2026 | 257 |
| 2 Nov 2026 | 241 |
| 1 Nov 2026 | 254 |
| 31 Oct 2026 | 253 |
| 30 Oct 2026 | 271 |
| 29 Oct 2026 | 313 |
| 28 Oct 2026 | 280 |
| 27 Oct 2026 | 265 |
WARN layoff notices
Notices filed under Elevance Health's own name or a subsidiary's listed in its 10-K.
Notices from 7 Nov 2023 to 7 Nov 2026
Elevance Health filed 4 notices covering 424 workers since November 2023.
| Notice | Place | Workers |
|---|---|---|
| 15 Sep 2026 | Metairie, LA | 216 |
| 27 Jul 2026 | DC | 85 |
| 15 Oct 2024 | Cerritos, CA | 64 |
| 15 Oct 2024 | Woodland Hills, CA | 59 |
Timeline
Leadership changes, layoffs and insider sales
7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025
1 departure and 3 appointments of directors and officers, WARN layoff notices on 2 days and 1 large insider sale in the last two years.
Insider sales of $1 million or more, and the largest tenth of Elevance Health's insider sales.
Events, newest first
- 22 Oct 2026 Mark Kaye sold $4.7MEVP & CFO
- 15 Sep 2026 216 workers in Metairie, LAWARN notice
- 27 Jul 2026 85 workers in DCWARN notice, effective 2 Oct 2026
- 26 Feb 2026 Peter D. Haytaian resignedExecutive Vice President and President of Carelon, effective 4 May 2026
- 26 Feb 2026 Peter D. Haytaian appointedSpecial Advisor
- 10 Dec 2025 Amy W. Schulman appointedIndependent director, effective 12 Jan 2026
- 28 Jul 2025 Steven H. Collis appointedIndependent director, effective 1 Aug 2025
| Date | Event | Filing |
|---|---|---|
| 22 Oct 2026 | Mark Kaye sold $4.7MEVP & CFO | Form 4 |
| 15 Sep 2026 | 216 workers in Metairie, LAWARN notice | WARN |
| 27 Jul 2026 | 85 workers in DCWARN notice, effective 2 Oct 2026 | WARN |
| 26 Feb 2026 | Peter D. Haytaian resignedExecutive Vice President and President of Carelon, effective 4 May 2026 | 8-K |
| 26 Feb 2026 | Peter D. Haytaian appointedSpecial Advisor | 8-K |
| 10 Dec 2025 | Amy W. Schulman appointedIndependent director, effective 12 Jan 2026 | 8-K |
| 28 Jul 2025 | Steven H. Collis appointedIndependent director, effective 1 Aug 2025 | 8-K |